Atlas Trials

Melatonin 3mg and 5mg Compared to Cognitive Behavioral Therapy for Insomnia (CBT-I) in the Treatment of Insomnia

Clinical trial NCT02798367 · UNKNOWN

Trial details

NCT number
NCT02798367
Sponsor
Ache Laboratorios Farmaceuticos S.A.
Status
UNKNOWN
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Insomnia Disorder
Start date
2018-03-22
Primary completion
2021-10-31
Enrollment
307

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.